Document is current
Any future updates will be listed below
-
Authors
Sato, Miki Takenaka https://orcid.org/0000-0002-0474-2007
Ida, Ayuki
Kanda, Yuki
Takano, Kaori
Ohbayashi, Masayuki
Kohyama, Noriko https://orcid.org/0000-0002-4681-5833
Morita, Jun https://orcid.org/0000-0002-4857-8683
Fuji, Kohzo https://orcid.org/0000-0002-2644-4238
Sasaki, Haruaki
Ogawa, Yoshio https://orcid.org/0000-0001-9542-2924
Kogo, Mari https://orcid.org/0000-0001-7553-0872
- License Information
-
More Information
Article History
Received: 21 December 2021
Accepted: 14 November 2022
First Online: 24 November 2022
Declarations
:
: This retrospective cohort study for metastatic renal cell carcinoma was approved by the Ethics Committee of the Showa University School of Pharmacy, Japan (Approval No. 366 on December 3, 2020). Given the retrospective nature of the study and the use of anonymous patient data, the requirement for obtaining informed consent was waived by the same Ethics Committee. The patients are informed that they are able to opt out from the use of their data for research purposes at the Showa University Hospital’s website. This study was performed in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.
